<!DOCTYPE html>
<html lang="en">
    <head>
		<title>Talks</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no" />
		<link rel="stylesheet" href="../assets/css/main.css" />
		<noscript><link rel="stylesheet" href="../assets/css/noscript.css" /></noscript>
	</head>
  <body class="is-preload">
    <!-- Navigation menu Start -->
		<header class="header" id="header">
			<nav class="nav container">
			  <div class="nav__menu" id="nav-menu">
				<ul class="nav__list">
				  <li class="nav__item">
					<a href="../index.html" class="nav__link">
						<i class="bi bi-arrow-up-right"></i>
						<span>Home</span>
					</a>
				  </li>
				  <li class="nav__item">
					<a href="publications.html" class="nav__link">
					  <i class="bi bi-arrow-up-right"></i>
					  <span>Publications</span>
					</a>
				  </li>
				  <li class="nav__item">
					<a href="talks.html" class="nav__link">
					  <i class="bi bi-arrow-up-right"></i>
					  <span>Talks</span>
					</a>
				  </li>
				  <!-- <li class="nav__item">
					<a href="team.html" class="nav__link">
					  <i class="bi bi-arrow-up-right"></i>
					  <span>Team</span>
					</a>
				  </li> -->
				  <li class="nav__item">
					<a href="cv.html" class="nav__link">
					  <i class="bi bi-arrow-up-right"></i>
					  <span>Biography</span>
					</a>
				  </li>
				</ul>
				<!-- Close End -->
				<!-- Social Start -->
				<div class="nav__social">
				  <a href="https://x.com/FuEdouard" target="_blank" class="nav__social-link">
					<i class="bi bi-instagram"><span class="icon brands style1 fa-x-twitter"></span></i>
				  </a>
				  <a href="https://www.linkedin.com/in/edouardfu/" target="_blank" class="nav__social-link">
					<i class="bi bi-github"><span class="icon brands style1 fa-linkedin-in"></span></i>
				  </a>
				  <a href="mailto: e.l.fu@lumc.nl" target="_blank" class="nav__social-link">
					<i class="bi bi-facebook"><span class="icon regular style1 fa-envelope"></span></i>
				  </a>
				</div>
				<!-- Sociel End -->
			  </div>
			  <!-- Toggle Start -->
			  <div class="nav__toggle" id="nav-toggle">
				<i class="bi bi-list"><span class="icon solid fa-bars"></span></i>
			  </div>
			  <!-- Toggle End -->
			</nav>
		  </header>
		  <!-- Navigation menu End -->

    <section class="spotlight style2 orient-left">
        <div class="content">
            <h2>Talks</h2>
			<p>The first table lists my invited lectures and mini-courses, including a link to an online recording if available. Underneath, my presentations of papers at congresses are listed. </p>
		</div>
		<div class="image">
			<img src="../images/award-lecture.jpg" alt="" />
		</div>
	</section>
	<section class="wrapper style1 align-left" id="invited-lectures">
		<div class="inner material table-responsive-vertical">		
			<h3>Courses and Invited lectures</h3>
            <table class="table table-hover">
				<thead>
				<tr>
					<th>Year</th><th>Presentation</th><th>Location</th><th>Link</th>
				</tr>
				</thead>
				<tbody>
				<tr>
					<td>2024</td><td>Lecture at JSN/ERA joint symposium</td><td>Japanese Society of Nephrology, Japan</td><td></td>
				</tr>
				<tr>
					<td>2024</td><td>Intermediate Course in Pharmacoepidemiology</td><td>Danish Society for Pharmacoepidemiology, Denmark</td><td></td>
				</tr>
				<tr>
					<td>2024</td><td>Lecture series (3 lectures) on target trial emulation</td><td>Dept of Clinical Epidemiology of Aarhus University, Denmark</td><td></td>
				</tr>
				<tr>
					<td>2023</td><td>Journal club clone-censor-weight</td><td>Harvard School of Public Health, USA</td><td></td>
				</tr>
				<tr>
					<td>2023</td><td>Lecture series (3 lectures) on target trial emulation</td><td>Karolinska Institute, Sweden</td><td></td>
				</tr>
				<tr>
					<td>2023</td><td>Lecture on "Drawing causal inference from observational studies in nephrology"</td><td>ERA congress Milan, Italy</td><td></td>
				</tr>
				<tr>
					<td>2023</td><td>Stanley Shaldon Award Lecture</td><td>ERA congress Milan, Italy</td><td><a href="https://www.youtube.com/watch?v=Ht1EqEqC-YU">YouTube</a></td>
				</tr>
				<tr>
					<td>2023</td><td>Lecture on "Target trial emulation: what, why and how?"</td><td>Kidney Health Research Collaborative, UCSF, USA</td><td></td>
				</tr>
				<tr>
					<td>2023</td><td>Lecture on "Safety of SGLT-2 inhibitors vs. GLP-1RA in patients with CKD and type 2 diabetes: U.S. cohort study"</td><td>Renal Disease Interest Group, Johns Hopkins University, USA</td><td></td>
				</tr>
				<tr>
					<td>2023</td><td>Lecture on "Using clone-censor-weight to study deprescribing: an application to RAS inhibitors in advanced CKD patients"</td><td>NorPEN (Nordic Pharmacoepidemiological Network)</td><td></td>
				</tr>
				<tr>
					<td>2023</td><td>Lecture on "Clinical research: description, prediction, causality"</td><td>Dutch Surgical Society for Medical Students, LUMC, The Netherlands</td><td></td>
				</tr>
				<tr>
					<td>2022</td><td>Guest lecturer in Clinical Data Science course (CI732)</td><td>Harvard Medical School, USA</td><td></td>
				</tr>
				<tr>
					<td>2022</td><td>Lecture on "Target trial emulation - what, why and how?"</td><td>Nephrology Grand Rounds, Ottawa Hospital, Canada </td><td><a href="https://www.youtube.com/watch?v=6L3-0I1EEGM">YouTube</a></td>
				</tr>
				<tr>
					<td>2022</td><td>Workshop on "Longitudinal data and time-to-event modelling"</td><td>LUMC, The Netherlands</td><td></td>
				</tr>
				<tr>
					<td>2022</td><td>Lecture on "Target trial emulation: A new standard for observational research"</td><td>University College London, UK</td><td></td>
				</tr>
				<tr>
					<td>2022</td><td>Lecture on "Implications for outcome studies on timing of dialysis initiation" (in the session "Why Nephrology needs Target Trial Emulation")</td><td>ERA-EDTA congress, Paris, France</td><td></td>
				</tr>
				<tr>
					<td>2022</td><td>Lecture on "Introduction to pharmaco-epidemiology" (Epidemiology Course: Advanced Statistical Approaches in Observational Clinical Research and Introduction to Pharmacoepidemiology)</td><td>World Congress of Nephrology</td><td></td>
				</tr>
				<tr>
					<td>2021</td><td>Lecture on "Target trial emulation in nephrology using observational data - a new paradigm"</td><td>Department of Medical Informatics, Amsterdam UMC, The Netherlands</td><td></td>
				</tr>
				<tr>
					<td>2021</td><td>Lecture on "Effectiveness and safety of renin-angiotensin system inhibitors in advanced kidney disease: nationwide cohort studies"</td><td>Harvard Medical School, USA</td><td></td>
				</tr>
				<tr>
					<td>2020</td><td>Course coordinator for Medicine in Numbers</td><td>Pre-University, LUMC, The Netherlands</td><td></td>
				</tr>
				<tr>
					<td>2020</td><td>Lecture on "Association between renal function decline after RAS-blockade and cardiorenal outcomes"</td><td>Honour College, LUMC, The Netherlands</td><td></td>
				</tr>
				<tr>
					<td>2019</td><td>Lecture on "Association of acute increases in creatinine after renin-angiotensin system blockade with subsequent outcomes"</td><td>Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden</td><td></td>
				</tr>
				<tr>
					<td>2018-2021</td><td>Instructor Epidemiology, BSc/MSc Medicine and Biomedical Sciences</td><td>LUMC, The Netherlands</td><td></td>
				</tr>
				</tbody>

			</table>
			<br>
			<h3 id="congresses">Orals at congresses</h3>
			<table class="table table-hover">
				<thead>
				<tr>
					<th>Congress</th><th>Presentation</th><th>Award</th>
				</tr>
				</thead>
				<tbody>
				<tr>
					<td>ERA 2024</td><td>Effect of dialysis vs. conservative care on all-cause mortality in older patients with advanced CKD (senior author)</td><td>Best abstract by young author</td>
				</tr>
				<tr>
					<td>ERA 2024</td><td>Measured glomerular filtration rate and risk of adverse outcomes in 6,059 patients from the Stockholm CREAtinine Measurements (SCREAM) project</td><td></td>
				</tr>
				<tr>
					<td>ICPE 2023</td><td>Effectiveness and safety of apixaban, rivaroxaban and warfarin in patients with advanced CKD and atrial fibrillation (free communication)</td><td></td>
				</tr>
				<tr>
					<td>ERA 2023</td><td>Effectiveness and safety of apixaban, rivaroxaban and warfarin in patients with advanced CKD and atrial fibrillation</td><td></td>
				</tr>
				<tr>
					<td>ERA 2023</td><td>Accuracy of estimated glomerular filtration rate equations in patients with discordances between creatinine and cystatin c-based estimations (moderated oral)</td><td></td>
				</tr>
				<tr>
					<td>ERA 2023</td><td>Accuracy of novel GFR estimating equations based on creatinine, cystatin c or both in routine care (focused oral)</td><td></td>
				</tr>
				<tr>
					<td>ERA 2022</td><td>Impact of removing race from the CKD-EPI equation: analysis of 1.6 million Swedish adults</td><td>Best abstract by young author</td>
				</tr>
				<tr>
					<td>ERA-EDTA 2021</td><td>When to initiate dialysis to reduce mortality and cardiovascular events in advanced CKD</td><td>Best abstract of congress</td>
				</tr>
				<tr>
					<td>ERA-EDTA 2021</td><td>Comparative effectiveness of SGLT2i versus DPP4i on cardiovascular and renal outcomes in routine-care settings (mini-oral)</td><td></td>
				</tr>
				<tr>
					<td>European Society of Cardiology 2020</td><td>Association between beta-blocker use and mortality/morbidity in patients with heart failure and advanced CKD</td><td>Selected for advances in science session</td>
				</tr>
				<tr>
					<td>Dutch Nephrology Days 2020</td><td>Beta-blockers are associated with reduced mortality in patients with heart failure with reduced ejection fraction and advanced chronic kidney disease: a cohort study</td><td></td>
				</tr>
				<tr>
					<td>ERA-EDTA 2020</td><td>Î²-blockers are associated with reduced mortality in patients with heart failure with reduced ejection fraction and advanced CKD: cohort study</td><td>Best abstract presented by young author</td>
				</tr>
				<tr>
					<td>ERA-EDTA 2020</td><td> Comparative effectiveness of renin-angiotensin system inhibitors and calcium channel blockers in individuals with advanced chronic kidney disease: a nationwide cohort study</td><td>ERA-EDTA Social Media Award</td>
				</tr>
				<tr>
					<td>ERA-EDTA 2019</td><td>Long-term cardiorenal outcomes associated with the acute increase of plasma creatinine following renin-angiotensin system blockade in a real-world setting</td><td>Best abstract presented by young author</td>
				</tr>
				<tr>
					<td>Dutch Nephrology Days 2019</td><td>Renin-angiotensin system inhibition, mortality and cardiorenal outcomes in advanced chronic kidney disease	</td><td></td>
				</tr>
				</tbody>

			</table>

		</div>
    </section>

    <!-- Scripts -->
    <script src="../assets/js/material_table.js"></script>
    <script src="../assets/js/navbar.js"></script>
    <script src="../assets/js/jquery.min.js"></script>
    <script src="../assets/js/jquery.scrollex.min.js"></script>
    <script src="../assets/js/jquery.scrolly.min.js"></script>
    <script src="../assets/js/browser.min.js"></script>
    <script src="../assets/js/breakpoints.min.js"></script>
    <script src="../assets/js/util.js"></script>
    <script src="../assets/js/main.js"></script>

  </body>
</html>
